Bridgebio Pharma, Inc.
BBIO
Revenue
116.63M
▲110.75M▲1882.88%
3 Months ChangeAssets
881.64M
▼-37.70M▼-4.10%
3 Months ChangeLiabilities
2.52B
▲143.35M▲6.03%
3 Months ChangeFree Cash Flow
-199.24M
▲21.00M▲9.53%
12 Months ChangeRevenue/Cost Of Revenue
Loading...
Net Profit/Loss
Loading...
Assets/Liabilities
Loading...
Cash Flows
Loading...
Loading...
Loading...
Recent Quarterly and Annual Filings
2024-09-11
Form 8-K
ID: 0001140361-24-040755
2024-08-21
Form 8-K
ID: 0001140361-24-037974
2024-08-01
Form 10-Q
ID: 0000950170-24-089326
2024-08-01
Form 8-K
ID: 0000950170-24-088952
2024-07-23
Form 8-K
ID: 0001140361-24-033856
2024-06-24
Form 8-K
ID: 0001140361-24-031087
2024-06-06
Form 8-K
ID: 0001140361-24-029050
2024-05-02
Form 10-Q
ID: 0000950170-24-052165
2024-05-02
Form 8-K
ID: 0000950170-24-051573
2024-03-06
Form 8-K
ID: 0001140361-24-011766